New target DDR1: A "double-edged sword" in solid tumors.

Tian, Yonggang; Bai, Feihu; Zhang, Dekui

Tian, Yonggang; Bai, Feihu; Zhang, Dekui.

Tian Y; Department of Gastroenterology, Lanzhou University Second Hospital, Lanzhou, Gansu Province, China.
Bai F; The Gastroenterology Clinical Medical Center of Hainan Province, Department of Gastroenterology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China. Electronic address: baifeihu@sohu.com.
Zhang D; Department of Gastroenterology, Lanzhou University Second Hospital, Lanzhou, Gansu Province, China. Electronic address: zhangdk8616@126.com.

Biochim Biophys Acta Rev Cancer ; 1878(1): 188829, 2023 01.

Article en En | MEDLINE | ID: mdl-36356724

Asunto(s)

Receptor con Dominio Discoidina 1; Neoplasias; Humanos; Receptor con Dominio Discoidina 1/genética; Receptor con Dominio Discoidina 1/metabolismo; Neoplasias/tratamiento farmacológico; Neoplasias/genética

Palabras clave

DDR1; Pathogenic mechanisms; Prognosis biomarker; Solid tumors; Targeting drugs

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptor con Dominio Discoidina 1 / Neoplasias Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google